The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
TGF-β signalling and its role in cancer progression and metastasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804 · cited 2×
“The expression of E-cadherin is repressed by TGF-β via SNAIL1/2, HMGA2 and ZEB1/2 [96].”
BackgroundEpithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545 · cited 1×
“Moreover, the cancer cells undergoing EMT have been found to show an increased resistance to apoptosis and to acquire traits reminiscent of those expressed by stem cells [100].”
BackgroundTGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337 · cited 1×
“Importantly for pancreatic cancer, loss of 18q21 also includes loss of both the DPC4 (Deleted in Pancreatic Carcinoma; SMAD4) and DCC (Deleted in Colorectal Carcinoma) genes [84].”
BackgroundInternational Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Non-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401 · cited 1×
“Several laboratories, including Weinberg [139], Moses [140], Sonnenschein [141] and Coussens [142], have provided evidence that the microenvironment composition, in conjunction with TGF-β, is a critical determinant of cancer progression.”
BackgroundCancer epidemiology biomarkers & prevention
Press, H. (1991) · Cited by 1,398
Distinct endocytic pathways regulate TGF-β receptor signalling and turnover
Di Guglielmo, G. M., Le Roy, C., Goodfellow, A. F., & Wrana, J. L. (2003) · Nature Cell Biology · doi:10.1038/ncb975 · Cited by 1,151
Strategies to improve radiotherapy with targeted drugs
Begg, A. C., Stewart, F. A., & Vens, C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3007 · Cited by 1,118
Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421358 · Cited by 1,033
Bone morphogenetic protein receptors and signal transduction
Miyazono, K., Kamiya, Y., & Morikawa, M. (2010) · Journal of Biochemistry · doi:10.1093/jb/mvp148 · Cited by 999
Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., & Arteaga, C. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005912200 · Cited by 992
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor
Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L., & Wrana, J. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81701-8 · Cited by 968
TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4
Padua, D., Zhang, X. H.-F., Wang, Q., Nadal, C., Gerald, W. L., Gomis, R. R., & Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.01.046 · Cited by 952
Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity
Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H.-R., Zhang, Y., & Wrana, J. L. (2005) · Science · doi:10.1126/science.1105718 · Cited by 881
Kimelman, D., & Kirschner, M. (1987) · Cell · doi:10.1016/0092-8674(87)90110-3 · Cited by 874
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
The regulation of TGFβ signal transduction
Moustakas, A., & Heldin, C.-H. (2009) · Development · doi:10.1242/dev.030338 · Cited by 832
Moustakas, A., & Heldin, C. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00550.x · Cited by 804
Reconstruction of functionally normal and malignant human breast tissues in mice
Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J. W., Carey, L., Richardson, A., & Weinberg, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401064101 · Cited by 804
Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation.
Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., & Massague, J. (1990) · Cell · doi:10.1016/0092-8674(90)90251-9 · Cited by 797
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.039 · Cited by 782
TGF- β signaling in cancer – a double-edged sword
Akhurst, R. J., & Derynck, R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02130-4 · Cited by 756
Genetic control of the circulating concentration of transforming growth factor type beta1
Grainger, D. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.93 · Cited by 755
Parsons, R. E., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1995) · PubMed · Cited by 738
Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor
Hata, A., Lagna, G., Massagué, J., & Hemmati-Brivanlou, A. (1998) · Genes & Development · doi:10.1101/gad.12.2.186 · Cited by 725
TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target?
Martin, M., Lefaix, J.-L., & Delanian, S. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00435-1 · Cited by 657
Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652
Anido, J., Sáez-Borderías, A., Gonzàlez-Juncà, A., Rodón, L., Folch, G., Carmona, M. A., Prieto-Sánchez, R. M., Barba, I., Martínez-Sáez, E., Prudkin, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.023 · Cited by 572
Lamouille, S., & Derynck, R. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611146 · Cited by 572
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
Pardali, K., & Moustakas, A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.004 · Cited by 526
Activation of the Erk Pathway Is Required for TGF-β1-Induced EMT In Vitro
Xie, L., Law, B. K., Chytil, A. M., Brown, K. A., Aakre, M. E., & Moses, H. L. (2004) · Neoplasia · doi:10.1593/neo.04241 · Cited by 523
E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression
Chen, C.-R., Kang, Y., Siegel, P. M., & Massagué, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00801-2 · Cited by 487
Direct interaction of two polarity complexes implicated in epithelial tight junction assembly
Hurd, T. W., Gao, L., Roh, M. H., Macara, I. G., & Margolis, B. (2003) · Nature Cell Biology · doi:10.1038/ncb923 · Cited by 486
BIERIE, B., & MOSES, H. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.006 · Cited by 477
Cell adhesion system and human cancer morphogenesis
Hirohashi, S., & Kanai, Y. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01485.x · Cited by 439
Molecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0234 · Cited by 435
Leight, J. L., Wozniak, M. A., Chen, S., Lynch, M. L., & Chen, C. S. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0537 · Cited by 425
Latent Transforming Growth Factor-β (TGF-β) Binding Proteins: Orchestrators of TGF-β Availability
Rifkin, D. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r400029200 · Cited by 420
The stroma as a crucial target in rat mammary gland carcinogenesis
Maffini, M. V., Soto, A. M., Calabro, J. M., Ucci, A. A., & Sonnenschein, C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01000 · Cited by 416
Frolik, C. A., Dart, L. L., Meyers, C. A., Smith, D. M., & Sporn, M. B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3676 · Cited by 398
Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J., Neumann, A., Brattain, M. G., Chang, J., Kim, S., et al. (1999) · PubMed · Cited by 391
Bhowmick, N. A., Zent, R., Ghiassi, M., McDonnell, M., & Moses, H. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106176200 · Cited by 388
Negative regulation of TGF-β receptor/Smad signal transduction
Itoh, S., & ten Dijke, P. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.015 · Cited by 388
Self-citationMolecular and Cell Biology of TGF-β
Roberts, A. B. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057358 · Cited by 386
TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase
Jang, C.-W., Chen, C.-H., Chen, C.-C., Chen, J.-Y., Su, Y.-H., & Chen, R.-H. (2002) · Nature Cell Biology · doi:10.1038/ncb731 · Cited by 386
How the Smads regulate transcription
Ross, S., & Hill, C. S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.09.006 · Cited by 383
Differentiation plasticity regulated by TGF-β family proteins in development and disease
Derynck, R., & Akhurst, R. J. (2007) · Nature Cell Biology · doi:10.1038/ncb434 · Cited by 382
Sánchez-Elsner, T., Botella, L. M., Velasco, B., Corbı́, A., Attisano, L., & Bernabéu, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104536200 · Cited by 380
Mechanisms of cancer metastasis to the bone
YIN, J. J., POLLOCK, C. B., & KELLY, K. (2005) · Cell Research · doi:10.1038/sj.cr.7290266 · Cited by 378
Mak, P., Leav, I., Pursell, B., Bae, D., Yang, X., Taglienti, C. A., Gouvin, L. M., Sharma, V. M., & Mercurio, A. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.030 · Cited by 372
Dunning, A. M., Ellis, P. D., McBride, S. E., Kirschenlohr, H. L., Healey, C. S., Kemp, P. R., Luben, R., Chang-Claude, J. C., Mannermaa, A., Kataja, V. V., et al. (2003) · PubMed · Cited by 370
Duenas-Gonzalez, A., Candelaria, M., Perez-Plascencia, C., Perez-Cardenas, E., de la Cruz-Hernandez, E., & Herrera, L. A. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.11.003 · Cited by 354
Soto, A. M., & Sonnenschein, C. (2011) · BioEssays · doi:10.1002/bies.201100025 · Cited by 349
MIYAZONO, K. (2009) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.85.314 · Cited by 337
Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., Mercola, D., Black, K. L., Royston, I., & Sobol, R. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2909 · Cited by 334
New regulatory mechanisms of TGF-β receptor function
Kang, J. S., Liu, C., & Derynck, R. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.05.008 · Cited by 328
Slingerland, J. M., Hengst, L., Pan, C. H., Alexander, D., Stampfer, M. R., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3683 · Cited by 324
Yamaguchi, K., Takagi, Y., Aoki, S., Futamura, M., & Saji, S. (2000) · Annals of Surgery · doi:10.1097/00000658-200007000-00009 · Cited by 323
Chen, C.-R., Kang, Y., & Massagué, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.992 · Cited by 320
Mechanisms of the Epithelial–Mesenchymal Transition by TGF-β
Wendt, M. K., Allington, T. M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/fon.09.90 · Cited by 317
Fuxe, J., Vincent, T., & Garcia de Herreros, A. (2010) · Cell Cycle · doi:10.4161/cc.9.12.12050 · Cited by 311
Wikström, P., Stattin, P., Franck-Lissbrant, I., Damber, J.-E., & Bergh, A. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980915)37:1<19::aid-pros4>3.0.co;2-3 · Cited by 307
AMH and AMH receptor defects in persistent Müllerian duct syndrome
Josso, N., Belville, C., di Clemente, N., & Picard, J.-Y. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi014 · Cited by 307
Yokota, M., Ichihara, S., Lin, T.-L., Nakashima, N., & Yamada, Y. (2000) · Circulation · doi:10.1161/01.cir.101.24.2783 · Cited by 299
Tsushima, H., Kawata, S., Tamura, S., Ito, N., Shirai, Y., Kiso, S., Imai, Y., Shimomukai, H., Nomura, Y., Matsuda, Y., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566583 · Cited by 284
Geng, Y., & Weinberg, R. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10315 · Cited by 277
C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells
Gomis, R. R., Alarcón, C., Nadal, C., Van Poznak, C., & Massagué, J. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.019 · Cited by 273
de Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<53::aid-path6>3.0.co;2-7 · Cited by 257
Latres, E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3496 · Cited by 257
The emerging role of TGF-β superfamily coreceptors in cancer
Bernabeu, C., Lopez-Novoa, J. M., & Quintanilla, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.003 · Cited by 254
Fransvea, E., Angelotti, U., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22201 · Cited by 253
TGF-β-induced epithelial to mesenchymal transition
Jian, J. I. A. N., Xü, Samy, Lamouille, Rik, & Derynck (2009) · Cell Research · Cited by 252
Zhang, M., Kleber, S., Röhrich, M., Timke, C., Han, N., Tuettenberg, J., Martin-Villalba, A., Debus, J., Peschke, P., Wirkner, U., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1212 · Cited by 249
Galliher, A. J., & Schiemann, W. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3851 · Cited by 249
c-myc Is a Downstream Target of the Smad Pathway
Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., & Kato, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104170200 · Cited by 244
Tachibana, I., Imoto, M., Adjei, P. N., Gores, G. J., Subramaniam, M., Spelsberg, T. C., & Urrutia, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119418 · Cited by 241
Bouquet, F., Pal, A., Pilones, K. A., Demaria, S., Hann, B., Akhurst, R. J., Babb, J. S., Lonning, S. M., DeWyngaert, J. K., Formenti, S. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0544 · Cited by 240
Genealogy, expression, and cellular function of transforming growth factor-β
Govinden, R., & Bhoola, K. D. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00035-4 · Cited by 239
Galliher, A. J., & Schiemann, W. P. (2006) · Breast Cancer Research · doi:10.1186/bcr1524 · Cited by 236
Nam, J.-S., Terabe, M., Mamura, M., Kang, M.-J., Chae, H., Stuelten, C., Kohn, E., Tang, B., Sabzevari, H., Anver, M. R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0215 · Cited by 233
The biology of activin: recent advances in structure, regulation and function
Xia, Y., & Schneyer, A. L. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0549 · Cited by 232
Frederick, J. P., Liberati, N. T., Waddell, D. S., Shi, Y., & Wang, X.-F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2546-2559.2004 · Cited by 221
Role of Ras Signaling in the Induction of Snail by Transforming Growth Factor-β
Horiguchi, K., Shirakihara, T., Nakano, A., Imamura, T., Miyazono, K., & Saitoh, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804777200 · Cited by 219
Rider, C. C., & Mulloy, B. (2010) · Biochemical Journal · doi:10.1042/bj20100305 · Cited by 215
Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis
Fong, S., Itahana, Y., Sumida, T., Singh, J., Coppe, J.-P., Liu, Y., Richards, P. C., Bennington, J. L., Lee, N. M., Debs, R. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2230238100 · Cited by 206
Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice.
Engle, S. J., Ormsby, I., Pawlowski, S. A., Boivin, G. P., Croft, J., Balish, E., & Doetschman, T. C. (2002) · PubMed · Cited by 199
Transforming growth factor-β in breast cancer: too much, too late
Barcellos-Hoff, M. H., & Akhurst, R. J. (2009) · Breast Cancer Research · doi:10.1186/bcr2224 · Cited by 187
Emergence, development and diversification of the TGF-β signalling pathway within the animal kingdom
Huminiecki, L., Goldovsky, L., Freilich, S., Moustakas, A., Ouzounis, C., & Heldin, C.-H. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-28 · Cited by 183
Friedman, E. D., Gold, L. I., Klimstra, D., Zeng, Z., Winawer, S. J., & Cohen, A. M. (1995) · PubMed · Cited by 182
Roles for the type III TGF-β receptor in human cancer
Gatza, C. E., Oh, S. Y., & Blobe, G. C. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.016 · Cited by 182
Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta
Teicher, B. A. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013177011767 · Cited by 177
Tian, F., Byfield, S. D., Parks, W. T., Yoo, S. S., Felici, A., Tang, B., Piek, E., Wakefield, L. M., & Roberts, A. B. (2003) · PubMed · Cited by 177
Dennler, S., Huet, S., & Gauthier, J.-M. (1999) · Oncogene · doi:10.1038/sj.onc.1202729 · Cited by 176
de Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<44::aid-path984>3.0.co;2-h · Cited by 169
Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP
Valderrama-Carvajal, H., Cocolakis, E., Lacerte, A., Lee, E.-H., Krystal, G., Ali, S., & Lebrun, J.-J. (2002) · Nature Cell Biology · doi:10.1038/ncb885 · Cited by 169
Copple, B. L. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02205.x · Cited by 164 · cited 1×
“addition, a hypoxic environment can induce EMT in cancer cells by working with components of the TGF-β pathway [136–138].”
BackgroundAndarawewa, K. L., Erickson, A. C., Chou, W. S., Costes, S. V., Gascard, P., Mott, J. D., Bissell, M. J., & Barcellos-Hoff, M. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1294 · Cited by 161
Smad4-mediated TGF-β signaling in tumorigenesis
Yang, G., & Yang, X. Y. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.1 · Cited by 159
TGF-β Signaling Alterations and Colon Cancer
Bellam, N., & Pasche, B. (2010) · Cancer treatment and research · doi:10.1007/978-1-4419-6033-7_5 · Cited by 158
Kirshner, J., Jobling, M. F., Pajares, M. J., Ravani, S. A., Glick, A. B., Lavin, M. J., Koslov, S., Shiloh, Y., & Barcellos-Hoff, M. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2565 · Cited by 158
Neil, J. R., Johnson, K. M., Nemenoff, R. A., & Schiemann, W. P. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn202 · Cited by 158
Wendt, M. K., & Schiemann, W. P. (2009) · Breast Cancer Research · doi:10.1186/bcr2360 · Cited by 158
Tsushima, H., Ito, N., Tamura, S., Matsuda, Y., Inada, M., Yabuuchi, I., Imai, Y., Nagashima, R., Misawa, H., Takeda, H., et al. (2001) · PubMed · Cited by 149
The effect of surgical wounding on tumour development
Hofer, S. O. P., Molema, G., Hermens, R., Wanebo, H. J., Reichner, J. S., & Hoekstra, H. J. (1999) · European Journal of Surgical Oncology · doi:10.1053/ejso.1998.0634 · Cited by 149
Transforming growth factor-beta1 mediates cellular response to DNA damage in situ.
Ewan, K., Henshall-Powell, R. L., Ravani, S. A., Pajares, M. J., Arteaga, C. L., Warters, R., Akhurst, R. J., & Barcellos‐Hoff, M. H. (2002) · PubMed · Cited by 142
The quarterly journal of nuclear medicine and molecular imaging
nucleare, A. I. D. M. (2004) · Cited by 142
Shim, K. S., Kim, K. H., Han, W. S., & Park, E. B. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<554::aid-cncr6>3.0.co;2-x · Cited by 138
TGF-β1–induced expression of human Mdm2 correlates with late-stage metastatic breast cancer
Araki, S., Eitel, J. A., Batuello, C. N., Bijangi-Vishehsaraei, K., Xie, X.-J., Danielpour, D., Pollok, K. E., Boothman, D. A., & Mayo, L. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39194 · Cited by 133
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer
Han, S., Kim, H.-T., Seong, D. H., Kim, Y. S., Park, Y., Bang, Y., Yang, H., & Kim, S. (2003) · Oncogene · doi:10.1038/sj.onc.1207259 · Cited by 131
Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia
Gobbi, H., Dupont, W. D., Simpson, J. F., Plummer, W. D., Schuyler, P. A., Olson, S. J., Arteaga, C. L., & Page, D. L. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2096 · Cited by 130
Donovan, J. C. H., & Slingerland, J. M. (2000) · Breast Cancer Research · doi:10.1186/bcr43 · Cited by 129
A role for the TGFβ-Par6 polarity pathway in breast cancer progression
Viloria‐Petit, A., David, L., Jia, J., Erdemir, T., Bane, A. L., Pinnaduwage, D., Roncari, L., Narimatsu, M., Bose, R., Moffat, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906796106 · Cited by 128
Bacman, D., Merkel, S., Croner, R. S., Papadopoulos, T., Brueckl, W. M., & Dimmler, A. W. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-156 · Cited by 126
The physical parameters and molecular events associated with radiation-induced lung toxicity
Vujašković, Ž., Marks, L. B., & Anscher, M. S. (2000) · Seminars in Radiation Oncology · doi:10.1053/srao.2000.9424 · Cited by 122
Anscher, M. S., Thrasher, B. A., Rabbani, Z. N., Teicher, B. A., & Vujašković, Ž. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.02.051 · Cited by 121
TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition
Hills, C. E., Siamantouras, E., Smith, S. W., Cockwell, P., Liu, K., & Squires, P. E. (2012) · Diabetologia · doi:10.1007/s00125-011-2409-9 · Cited by 115
Ewan, K., Oketch‐Rabah, H. A., Ravani, S. A., Shyamala, G., Moses, H. L., & Barcellos‐Hoff, M. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62985-9 · Cited by 115
TGF Beta Inhibition for Cancer Therapy
Saunier, E. F., & Akhurst, R. J. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906778742460 · Cited by 114
(2013) · Annals of Surgical Oncology · doi:10.1007/10434.1534-4681 · Cited by 112
Distinct Genetic Alterations in Colorectal Cancer
Ashktorab, H., Schäffer, A. A., Daremipouran, M., Smoot, D. T., Lee, E. B., & Brim, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008879 · Cited by 111
Lamouille, S., & Derynck, R. (2010) · Cells Tissues Organs · doi:10.1159/000320172 · Cited by 104
Kretzschmar, M. (2000) · Breast Cancer Research · doi:10.1186/bcr42 · Cited by 103
Robson, H., Anderson, E., James, R., & Schofield, P. F. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.432 · Cited by 103
Ohmori, T., Yang, J.-L., Price, J. O., & Arteaga, C. L. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4261 · Cited by 98
Smad3 regulates E-cadherin via miRNA-200 pathway
Ahn, S.-M., Cha, J.-Y., Kim, J., Kim, D., Trang, H. T. H., Kim, Y.-M., Yh, C., Park, D., & Hong, S. (2011) · Oncogene · doi:10.1038/onc.2011.484 · Cited by 98
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancerPreprint
Matsumura, N., Huang, Z., Mori, S., Baba, T., Fujii, S., Konishi, I., Iversen, E. S., Berchuck, A., & Murphy, S. K. (2010) · Genome Research · doi:10.1101/gr.108803.110 · Cited by 95
Edme, N., Downward, J., Thiery, J. P., & Boyer, B. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.12.2591 · Cited by 90
Identification of a Novel Member (GDF-1) of the Transforming Growth Factor-β Superfamily
Lee, S. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-7-1034 · Cited by 90
Wallace, A. F., Kapoor, V., Sun, J., Mrass, P., Weninger, W., Heitjan, D. F., June, C. H., Kaiser, L. R., Ling, L. E., & Albelda, S. Μ. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0356 · Cited by 87
Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?
Wang, Z., Chen, C., Finger, S. N., Kwajah, S., Jung, M., Schwarz, H., Swanson, N. R., Lareu, R. R., & Raghunath, M. (2009) · European Respiratory Journal · doi:10.1183/09031936.00084808 · Cited by 87
Fu, K., Corbley, M. J., Sun, L., Friedman, J. E., Shan, F., Papadatos, J. L., Costa, D. E., Lutterodt, F., Sweigard, H., Bowes, S., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.158030 · Cited by 85
Santibanez, J. F., Blanco, F. J., Garrido-Martin, E. M., Sanz-Rodríguez, F., del Pozo, M. Á., & Bernabéu, C. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm097 · Cited by 83
Wendt, M. K., Smith, J. A., & Schiemann, W. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023614 · Cited by 78
Lücke, C. D., Philpott, A., Metcalfe, J. C., Thompson, A. M., Hughes‐Davies, L., Kemp, P. R., & Hesketh, R. (2001) · PubMed · Cited by 76
Biswas, S., Trobridge, P., Romero–Gallo, J., Billheimer, D. D., Myeroff, L. L., Willson, J. K. V., Markowitz, S. D., & Grady, W. M. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20511 · Cited by 75
Inhibition of Smad Antiproliferative Function by CDK Phosphorylation
Liu, F., & Matsuura, I. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1366 · Cited by 67
When versatility matters: activins/inhibins as key regulators of immunity
Alemán-Muench, G. R., & Soldevila, G. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.32 · Cited by 66
TGFβ and cancer metastasis: an inflammation link
Yang, L. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9226-3 · Cited by 65
Burdak‐Rothkamm, S., & Prise, K. M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.068 · Cited by 65
Phase I Trial of TGF-β2 Antisense GM-CSF Gene-Modified Autologous Tumor Cell (TAG) Vaccine
Olivares, J., Kumar, P., Yu, Y., Maples, P. B., Senzer, N. N., Bedell, C., Barve, M. A., Tong, A., Pappen, B. O., Kuhn, J. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2195 · Cited by 64
Guan, F., Schaffer, L., Handa, K., & Hakomori, S. (2010) · The FASEB Journal · doi:10.1096/fj.10-162107 · Cited by 64
Tian, M., & Schiemann, W. P. (2009) · The FASEB Journal · doi:10.1096/fj.09-141341 · Cited by 63
Molecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-07-0234 · Cited by 62
Transforming growth factor-β in in vivo resistance
Teicher, B. A., Holden, S. A., Ara, G., & Chen, G. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050435 · Cited by 59
TGF-β Signaling Pathway and Breast Cancer Susceptibility
Scollen, S., Luccarini, C., Baynes, C., Driver, K. E., Humphreys, M. K., García‐Closas, M., Figueroa, J. D., Lissowska, J., Pharoah, P. D. P., Easton, D. F., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0062 · Cited by 55
Shima, K., Morikawa, T., Yamauchi, M., Kuchiba, A., Imamura, Y., Liao, X., Meyerhardt, J. A., Fuchs, C. S., & Ogino, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025062 · Cited by 53
Reversal of in vivo drug resistance by the transforming growth factor-β inhibitor decorin
Teicher, B. A., Maehara, Y., Kakeh, Y., Ara, G., Keyes, S. R., Wong, J. S., & Herbst, R. S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970328)71:1<49::aid-ijc10>3.0.co;2-4 · Cited by 52
Wiegman, E. M., Bläse, M., Loeffler, H., Coppes, R. P., & Rodemann, H. P. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.013 · Cited by 50
Samanta, D., Gonzalez, A. L., Nagathihalli, N. S., Ye, F., Carbone, D. P., & Datta, P. K. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0313 · Cited by 44
Teicher, B. A., Ikebe, M., Ara, G., Keyes, S. R., & Herbst, R. S. (1997) · PubMed · Cited by 42
Barlow, J., Yandell, D. W., Weaver, D. L., Casey, T., & Plaut, K. I. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023918026437 · Cited by 40
Antisense TGF-?2 Immunotherapy for Hepatocellular Carcinoma: Treatment in a Rat Tumor Model
Maggard, M. A., Meng, L., Ke, B., Allen, R. B., Devgan, L. L., & Imagawa, D. K. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0032-6 · Cited by 39
Funkenstein, B., Olekh, E., & Jakowlew, S. B. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-37 · Cited by 39
Lampropoulos, P., Zizi-Sermpetzoglou, A., Rizos, S., Kostakis, A. I., Nikiteas, N. I., & Papavassiliou, A. G. (2012) · Tumor Biology · doi:10.1007/s13277-012-0333-3 · Cited by 36
Xu, G., Chakraborty, C., & Lala, P. K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02845-0 · Cited by 35
Kusakabe, M., Cheong, P. L., Nikfar, R., McLennan, I. S., & Koishi, K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21407 · Cited by 35
Antony, M. L., Nair, R. P., Sebastian, P., & Karunagaran, D. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0703-4 · Cited by 35
Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif
Makkar, P., Metpally, R. P. R., Sangadala, S., & Reddy, B. V. B. (2008) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2008.12.003 · Cited by 35
Left-right patterning in the mouse requires Epb4.1l5-dependent morphogenesis of the node and midline
Lee, J. D., Migeotte, I., & Anderson, K. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.07.029 · Cited by 32
Gałat, A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0643-4 · Cited by 31
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2mutation carriers
Walker, L. C., Fredericksen, Z. S., Wang, X., Tarrell, R. F., Pankratz, V. S., Lindor, N. M., Beesley, J., Healey, S. C., Chen, X., kConFab, et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2785 · Cited by 30
Sflomos, G., Kostaras, E., Panopoulou, E., Pappas, N., Kyrkou, A., Politou, A. S., Fotsis, T., & Murphy, C. (2011) · Journal of Cell Science · doi:10.1242/jcs.062307 · Cited by 30
Yong, L. I. U., Kudo, K., Abe, Y., Hu, D., Kijima, H., Nakane, A., & Ono, K. (2009) · Journal of Radiation Research · doi:10.1269/jrr.08112 · Cited by 27
TGF-β signalling and immunity in prostate tumourigenesis
Diener, K. R., Need, E. F., Buchanan, G., & Hayball, J. D. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903544507 · Cited by 26
Tram, E., Ibrahim-zada, I., Briollais, L., Knight, J. A., Andrulis, I. L., & Özçelik, H. (2011) · Breast Cancer Research · doi:10.1186/bcr2926 · Cited by 18
Arany, P. R., Flanders, K. C., DeGraff, W., Cook, J. A., Mitchell, J. B., & Roberts, A. B. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.05.012 · Cited by 15
Examination of Smad2 and Smad4 copy-number variations in skin cancers
Shao, Y., Zhang, J., Zhang, R., Wan, J., Zhang, W., & Yu, B. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0773-7 · Cited by 13
Pandey, J. P., Umphress, S. M., Kang, Y., Angdisen, J. J., Naumova, A. V., Mercer, K. L., Jacks, T., & Jakowlew, S. B. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm136 · Cited by 11
Cited by
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Targeting TGF-β Signaling in Cancer
Colak, S., & ten Dijke, P. (2017) · Trends in cancer · doi:10.1016/j.trecan.2016.11.008 · Cited by 1,003
Apoptosis, autophagy, necroptosis, and cancer metastasis
Su, Z., Yang, Z., Xu, Y., Chen, Y., & Yu, Q. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0321-5 · Cited by 1,042
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Xu, F., Liu, C., Zhou, D., & Zhang, L. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415627681 · Cited by 756
Chakravarthy, A., Khan, L., Bensler, N. P., Bose, P., & De Carvalho, D. D. (2018) · Nature Communications · doi:10.1038/s41467-018-06654-8 · Cited by 656
Metadata
- Authors
- Drabsch, Y., & ten Dijke, P.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2012-06-20
- Volume
- 31
- Issue
- 3-4
- Pages
- 553-568
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1970195787
- Cited by
- 428
- References
- 181
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.